Carprodyl Quadri 50mg 100's
Item No. 90139
DESCRIPTION: Indication in dogs for the reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease and as a follow-up to parenteral analgesia in the management of post-operative pain. It is indicated for oral administration at a rate of 4 mg carprofen per
Description
DESCRIPTION:
Indication in dogs for the reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease and as a follow-up to parenteral analgesia in the management of post-operative pain. It is indicated for oral administration at a rate of 4 mg carprofen per kg bodyweight per day.
Indication in dogs for the reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease and as a follow-up to parenteral analgesia in the management of post-operative pain. It is indicated for oral administration at a rate of 4 mg carprofen per kg bodyweight per day.
Specifications
- Species
- Companion Animal
- Business Unit
- Small Animal
- HPRA SPC Link
- https://www.hpra.ie/img/uploaded/swedocuments/LicenseSPC_10815-045-001_24032017154024.pdf
- Legal catagory
- POM
- Active/Ingredient(s)
- Carprofen
Carprodyl Quadri 50mg 100's
Item No. 90139
DESCRIPTION: Indication in dogs for the reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease and as a follow-up to parenteral analgesia in the management of post-operative pain. It is indicated for oral administration at a rate of 4 mg carprofen per
Description
DESCRIPTION:
Indication in dogs for the reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease and as a follow-up to parenteral analgesia in the management of post-operative pain. It is indicated for oral administration at a rate of 4 mg carprofen per kg bodyweight per day.
Indication in dogs for the reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease and as a follow-up to parenteral analgesia in the management of post-operative pain. It is indicated for oral administration at a rate of 4 mg carprofen per kg bodyweight per day.
Specifications
- Species
- Companion Animal
- Business Unit
- Small Animal
- HPRA SPC Link
- https://www.hpra.ie/img/uploaded/swedocuments/LicenseSPC_10815-045-001_24032017154024.pdf
- Legal catagory
- POM
- Active/Ingredient(s)
- Carprofen